✦ LIBER ✦

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

✍ Scribed by George, S.; Wang, Q.; Heinrich, M. C.; Corless, C. L.; Zhu, M.; Butrynski, J. E.; Morgan, J. A.; Wagner, A. J.; Choy, E.; Tap, W. D.; Yap, J. T.; Van den Abbeele, A. D.; Manola, J. B.; Solomon, S. M.; Fletcher, J. A.; von Mehren, M.; Demetri, G. D.

Book ID: 127290516
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 248 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2011.39.9394

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of dovitinib in patients

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

✍ Kang, Y-K; Yoo, C; Ryoo, B-Y; Lee, J J; Tan, E; Park, I; Park, J H; Choi, Y J; J 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 682 KB

Efficacy and safety of sunitinib in pati

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

✍ George D Demetri; Allan T van Oosterom; Christopher R Garrett; Martin E Blackste 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 201 KB

Efficacy and safety of regorafenib for a

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

✍ Demetri, George D; Reichardt, Peter; Kang, Yoon-Koo; Blay, Jean-Yves; Rutkowski, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 348 KB

3535 POSTER Phase II trial investigating

3535 POSTER Phase II trial investigating the efficacy and safety of sunitinib in patients with unresectable hepatocellular carcinoma (HCC)

✍ S.J. Faivre; E. Raymond; J. Douillard; E. Boucher; H.Y. Lim; J.S. Kim; S. Lanzal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II trial of temozolomide in pati

A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma

✍ Susan M. Talbot; Mary Louise Keohan; Mary Hesdorffer; Russell Orrico; Emilia Bag 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable or metastatic soft tissue sarcoma. ## METHODS Twenty‐five of 26 patients were eligible and assessable for toxicity and resp

Multicenter Phase II trial of high-dose

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma : Significant toxicity with no clinical efficacy

✍ Ken Wyman; Michael B. Atkins; Victor Prieto; Omar Eton; David F. McDermott; Fran 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB